Green Chemistry Articles of Interest to the Pharmaceutical Industry
The American Chemical Society (ACS) Green Chemistry Institute (GCI) Pharmaceutical Roundtable (PR) was developed in 2005 to encourage the integration of green chemistry and green engineering into the pharmaceutical industry. The ACS GCI is a not-for-profit organization whose mission is to catalyze and enable the implementation of green and sustainable chemistry throughout the global chemistry enterprise. The ACS GCI PR is composed of pharmaceutical and biotechnology companies, including contract research/ manufacturing organizations and generic pharmaceuticals. For details of the current membership, see acsgcipr.org. Reviews covering Green Chemistry articles of interest from a pharmaceutical perspective are periodically disclosed.
Bryan, M. C.; Dalton, C.; Doerfler, J.; Engl, O. D.; Ferguson, P.; Molina, A. G.; Harawa, V.; Hosford, J.; Howell, G. P. Kelly, C. B.; Li, W.; Munday, R. H.; Navarro, A.; Parmentier, M.; Pawlas, J.; Richardson, P. F.; Steven, A.; Takale, B. S.; Terrett, J. A.; Treitler, D. S.; Zeng, M. Green Chemistry Articles of Interest to the Pharmaceutical Industry. Org. Process Res. Dev. 2022, 26, 2550–2559.